Filed: Oct. 02, 2014
Latest Update: Oct. 02, 2014
Summary: ORDER DAVID R. STRAWBRIDGE, Magistrate Judge. AND NOW this 1st day of October, 2014, for the reasons set forth in the attached Memorandum Opinion, it is hereby ORDERED that Defendants' Joint Motion to Exclude Testimony of Plaintiff Apotex, Inc.'s Fed. R. Evid. 701 Witness, Gordon Fahner (Doc. 683), filed by Cephalon, Inc., Barr Laboratories, Inc., Mylan, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Limited a
Summary: ORDER DAVID R. STRAWBRIDGE, Magistrate Judge. AND NOW this 1st day of October, 2014, for the reasons set forth in the attached Memorandum Opinion, it is hereby ORDERED that Defendants' Joint Motion to Exclude Testimony of Plaintiff Apotex, Inc.'s Fed. R. Evid. 701 Witness, Gordon Fahner (Doc. 683), filed by Cephalon, Inc., Barr Laboratories, Inc., Mylan, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Limited an..
More
ORDER
DAVID R. STRAWBRIDGE, Magistrate Judge.
AND NOW this 1st day of October, 2014, for the reasons set forth in the attached Memorandum Opinion, it is hereby ORDERED that Defendants' Joint Motion to Exclude Testimony of Plaintiff Apotex, Inc.'s Fed. R. Evid. 701 Witness, Gordon Fahner (Doc. 683), filed by Cephalon, Inc., Barr Laboratories, Inc., Mylan, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Limited and Teva Pharmaceuticals USA, Inc. is GRANTED.
